Підписатись
Miloš Miljković
Miloš Miljković
Cartesian Therapeutics
Підтверджена електронна адреса в cartesiantx.com - Домашня сторінка
Назва
Посилання
Посилання
Рік
Cytokines in the Treatment of Cancer
KC Conlon, MD Miljkovic, TA Waldmann
Journal of Interferon & Cytokine Research 39 (1), 6-21, 2019
5352019
IL-15 in the combination immunotherapy of cancer
TA Waldmann, S Dubois, MD Miljkovic, KC Conlon
Frontiers in immunology 11, 868, 2020
1942020
IL15 by continuous intravenous infusion to adult patients with solid tumors in a phase I trial induced dramatic NK-cell subset expansion
KC Conlon, EL Potter, S Pittaluga, CCR Lee, MD Miljkovic, TA Fleisher, ...
Clinical Cancer Research 25 (16), 4945-4954, 2019
1242019
Interleukin-15 (dys) regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer
TA Waldmann, MD Miljkovic, KC Conlon
Journal of Experimental Medicine 217 (1), 2020
1222020
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised …
V Granit, M Benatar, M Kurtoglu, MD Miljković, N Chahin, G Sahagian, ...
The Lancet Neurology 22 (7), 578-590, 2023
1132023
Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade
DA Rauch, KC Conlon, M Janakiram, JE Brammer, JC Harding, BH Ye, ...
Blood, The Journal of the American Society of Hematology 134 (17), 1406-1414, 2019
1052019
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making
C Melani, R Advani, M Roschewski, KM Walters, CC Chen, L Baratto, ...
Haematologica 103 (8), 1337, 2018
852018
Potential cost implications for All US Food and drug administration oncology drug approvals in 2018
PC DeMartino, MD Miljković, V Prasad
JAMA Internal Medicine 181 (2), 162-167, 2021
452021
Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies
SP Dubois, MD Miljkovic, TA Fleisher, S Pittaluga, J Hsu-Albert, BR Bryant, ...
Journal for immunotherapy of cancer 9 (4), 2021
412021
Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for Oncologists
M Sorigue, MD Miljkovic
Journal of Oncology Practice 15 (12), 641-650, 2019
342019
“Allow Natural Death” versus “Do Not Resuscitate”: What Do Patients with Advanced Cancer Choose?
MD Miljković, D Emuron, L Rhodes, J Abraham, K Miller
Journal of palliative medicine 18 (5), 457-460, 2015
342015
NF-κB–induced R-loop accumulation and DNA damage select for nucleotide excision repair deficiencies in adult T cell leukemia
Y He, N Pasupala, H Zhi, B Dorjbal, I Hussain, HM Shih, S Bhattacharyya, ...
Proceedings of the National Academy of Sciences 118 (10), e2005568118, 2021
322021
Morphometric study of healthy jejunal and ileal mucosa in adult and aged subjects
JB Trbojević-Stanković, NM Milicevic, DP Milošević, N Despotović, ...
Histology and histopathology, 2010
282010
Association Between US Drug Price and Measures of Efficacy for Oncology Drugs Approved by the US Food and Drug Administration From 2015 to 2020
MD Miljković, JE Tuia, T Olivier, A Haslam, V Prasad
JAMA Internal Medicine 182 (12), 1319-1320, 2022
252022
Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia
M Sorigue, L Magnano, MD Miljkovic, J Nieto‐Moragas, M Santos‐Gomez, ...
Cytometry Part B: Clinical Cytometry 98 (5), 441-448, 2020
232020
Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL
MD Miljkovic, C Melani, S Pittaluga, R Lakhotia, N Lucas, A Jacob, ...
Blood Advances 5 (20), 4198-4210, 2021
222021
Novel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors
MD Miljković, M Girotra, RR Abraham, RB Erlich
Digestive diseases and sciences 57 (1), 9-18, 2012
212012
Phase 1b/2 study of Vipor (Venetoclax, Ibrutinib, prednisone, Obinutuzumab, and Lenalidomide) in relapsed/refractory B-cell lymphoma: safety, efficacy and molecular analysis
C Melani, R Lakhotia, S Pittaluga, MD Miljkovic, JD Phelan, JR Muppidi, ...
Blood 136, 44-45, 2020
202020
Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies
MD Miljkovic, SP Dubois, JR Müller, B Bryant, E Ma, KC Conlon, ...
Blood Advances 7 (3), 384-394, 2023
172023
Use of endoscopic ultrasound in diagnosing plasmacytoma of the pancreas
V Senadhi
JOP. Journal of the Pancreas 13 (1), 26-29, 2012
152012
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20